Pharmacogenetic testing prior to carbamazepine treatment of epilepsy: patients' and physicians' preferences for testing and service delivery

AIM: Pharmacogenetic studies have identified the presence of the HLA-A*31:01 allele as a predictor of cutaneous adverse drugs reactions (ADRs) to carbamazepine. This study aimed to ascertain the preferences of patients and clinicians to inform carbamazepine pharmacogenetic testing services. METHODS:...

全面介紹

Na minha lista:
書目詳細資料
發表在:Br J Clin Pharmacol
Main Authors: Powell, Graham, Holmes, Emily A F, Plumpton, Catrin O, Ring, Adele, Baker, Gus A, Jacoby, Ann, Pirmohamed, Munir, Marson, Anthony G, Hughes, Dyfrig A
格式: Artigo
語言:Inglês
出版: John Wiley & Sons, Ltd 2015
主題:
Pharmacogenetics
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4631187/
https://ncbi.nlm.nih.gov/pubmed/26138622
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12715
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍